a-actin
|
alpha-actin |
ActRIIB
|
activin receptor type 2B |
ALS
|
amyotrophic lateral sclerosis |
Ang II
|
angiotensin II |
ANP
|
atrial natriuretic peptide |
AT
|
acidic tail |
AT1R
|
angiotensin II receptor type 1 |
Bb2
|
B-box type 2 domain |
bHLH
|
basic helix-loop-helix |
Bif-1
|
BAX interacting factor 1 |
C/EBP
|
CCAAT/enhancer binding protein |
CARP
|
ubiquitin carboxyl-terminal hydrolase MINDY-3 |
CC
|
coiled-coil domain |
CHOP
|
C/EBP homologous protein |
CHRN
|
cholinergic receptor nicotinic/nicotinic acetylcholine receptor |
CK
|
creatine kinase |
cMyBP-C
|
cardiac MyBP-C isoform |
can
|
calcineurin |
COS box
|
C-terminal subgroup one signature-box |
CRL4
|
Cullin-RING-based E3 ubiquitin-protein ligase 4 |
CSA
|
cross-sectional area; Dex, dexamethasone |
dKO
|
double knock-out |
EDL
|
extensor digitorium longus muscle |
EndoB1
|
endophilin B1 |
EPR
|
electron paramagnetic resonance |
FoxO
|
forkhead box family of transcription factors |
GME
|
glucocorticoid modulatory elements |
GMEB1
|
glucocorticoid modulatory element binding protein-1 |
GR
|
glucocorticoid receptor |
HCM
|
hypertrophic cardiomyopathy |
HD
|
helical domain |
HIBADH
|
3-hydroxyisobutyrate dehydrogenase |
ICU
|
intensive care unit |
IGF-1
|
insulin-like growth factor 1 |
IL1
|
interleukine 1 |
I/R
|
ischemia/reperfusion |
JNK
|
c-Jun N-terminal kinases |
KO
|
knock-out |
LAMP1
|
lyososomal-associated membrane protein 1 |
LC3
|
microtubule-associated proteins 1A/1B light chain 3b |
M1/M2 dKO
|
homozygous constitutive null mutants for MuRF1 or MuRF2 |
MAFbx
|
muscle atrophy F-box protein |
MCT
|
monocrotaline |
MEF2
|
myocyte enhancer factor-2 |
MFC
|
MuRF family specific motif |
MHC
|
myosin heavy chain |
MHCIIa
|
myosin heavy chain type IIa |
MI
|
myocardial infarction |
MLC
|
myosin light chain |
MLP/Csrp3
|
muscle limp protein/cystine and glycine-rich protein 3 |
MCK
|
muscle-type creatine kinase |
mTORC1
|
mammalian target of rapamycin complex 1 |
MuRF
|
muscle-specific RING finger protein |
MuRF1-KO
|
transgenic mice specifically silenced for MuRF1 |
MuRF1-TG
|
transgenic mice specifically over-expressing MuRF1 in skeletal muscle |
MuRF1-Tg+
|
transgenic mice expressing increased levels of MuRF1 specifically in the heart |
MuRF1-
ΔRING
|
transgenic mice with a mutant dominant negative form of MuRF1 corresponding to a RING-deletion of MuRF1 |
MyBP-C
|
myosin binding prot-C |
MHC
|
myosin heavy chain |
NF-kB
|
nuclear factor kappa-light-chain-enhancer of activated B cells |
NFAT
|
nuclear factor of activated T cells |
NRVM
|
neonatal rat ventricular myocytes |
O-MCK
|
oxidized form of MCK |
PE
|
phenylephrine |
PDH
|
pyruvate dehydrogenase |
PDK2
|
pyruvate dehydrogenase kinase isoform 2 |
PI3K
|
phosphoinositide 3-kinase |
polyUb
|
polyubiquitination |
PMA
|
plasma membrane ATPase |
PPARα
|
peroxisome proliferator activated receptors |
PPRE
|
PPAR response element |
RACK1
|
receptor of activated protein C kinase 1 |
RBCC
|
RING-B box-coiled-coil |
RING
|
really interesting new gene |
ROS
|
reactive oxygen species |
SPR
|
surface plasmon resonance |
SQTM1/p62
|
Sequestosome-1 |
SRF
|
serum response factor |
SUMO
|
small ubiquitin-related modifier |
TAC
|
transaortic constriction model |
TFEB
|
transcription factor EB |
TNF
|
transforming growth factor |
TnnI, TnnC
|
troponin I and C |
TRAF6
|
TNF receptor associated factors 6 |
TRIP12
|
thyroid receptor-interacting protein 12 |
TRIM
|
tripartite motif family |
UPS
|
ubiquitin-proteasome system |
WT
|
wild-type |
Y2H
|
yeast two-hybrid. |